Country Profile

Mongolia

Mongolia is an emerging destination for Indian pharmaceutical exports — $7.55M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $1.52M. The compound annual growth rate since FY2015 stands at 12.0%.

🇲🇳 $7.55M · 3.5× growth since FY2015 · 12.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$7.55M
Exports FY2025–26 DGCIS
3.5×
Growth FY2015→2026
12.0%
CAGR FY2015→2026
71%
Medicines Share
4
Product Categories Supplied
Mongolia is an emerging destination for Indian pharmaceutical exports — $7.55M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $1.52M. The compound annual growth rate since FY2015 stands at 12.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $5.38M (71.2%) Vaccines $1.52M (20.1%) Traditional & Herbal $531K (7.0%) Surgical & Hospital Supplies $126K (1.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Mongolia in the RBI overseas direct investment dataset (2011–2026).